Montes Claros confirma primeiro caso de mpox em 2026
“É importante que as pessoas fiquem atentas aos sintomas como as feridas, que são mais características, e procurem uma Unidade Básica de Saúde para fazer a testagem,” said Eduardo Prosdocimi, subsecretary of Health Surveillance at Minas Gerais’s State Health Secretariat.
His warning came as health officials in Montes Claros confirmed the city’s first mpox case of 2026.
The patient is a 41-year-old man whose diagnosis was confirmed by laboratory testing on Monday, November 16, the Montes Claros municipal government said. The first symptoms appeared on November 4, while the man was still in Montes Claros.
Five days later, on November 9, he sought medical care with a set of symptoms that included fever, chills, headache, abdominal pain, diarrhea, sore throat, a urinary infection, and skin blotches and eruptions. The case was formally notified as suspect on November 11.
According to the epidemiological investigation cited by the municipal government, the man told health officials he had recently traveled to Belo Horizonte, where he also maintains a fixed residence, and to Janaúba in northern Minas Gerais.
He denied having contact with anyone showing similar symptoms. As soon as the laboratory result came back, the municipal network identified everyone who had contact with the man, and preventive follow-up is being carried out by the Family Health Strategy teams responsible for his area.
Key Clinical Takeaways:

- Montes Claros has confirmed its first mpox case of 2026, in a 41-year-old man diagnosed on November 16.
- State health officials report no severe cases or hospitalizations in Minas Gerais so far this year, but surveillance has been intensified.
- There is no specific treatment for mpox; care focuses on relieving symptoms and preventing complications, and vaccination is limited to defined risk groups.
Montes Claros enters the state count
The confirmation puts Montes Claros on the state’s mpox map for 2026. Neighboring Divinópolis has confirmed two cases this year and is investigating two other suspects, while Juiz de Fora ranks as the second city in Minas Gerais with the most confirmed mpox cases in 2026, according to Globo. Divinópolis has released details of the first care provided to an mpox patient there.
Statewide, the picture is one of decline. The State Health Secretariat counted 41 confirmed cases between January and November, with the highest concentration among men aged 15 to 34. By comparison, 136 cases were notified in 2025 and 68 in 2024. Prosdocimi said the state has “no severe cases or hospitalizations,” but that prevention measures remain necessary.
Why mpox keeps demanding attention
Mpox is caused by the mpox virus (MPXV), an infection that runs a mild to moderate course in most people. Transmission occurs through direct contact with skin lesions, sexual contact, bodily or respiratory secretions, and sharing of contaminated objects.
Laboratory diagnosis analyzes secretions or crusts from lesions; in Minas Gerais, samples go to the Central Public Health Laboratory (Lacen-MG/Funed) and to decentralized units in Juiz de Fora and Diamantina, according to Estado de Minas.
There is no specific treatment. Care focuses on symptom relief and preventing complications, which is why early testing matters: identifying lesions characteristic of mpox and seeking care at a basic health unit, as Prosdocimi urged, shortens the window in which a patient can transmit the virus undetected.
The WHO’s mpox fact sheet lists isolation of cases and contact tracing as core containment measures — the same steps Montes Claros’s Family Health Strategy teams are now applying.
Who qualifies for vaccination
Vaccination in Minas Gerais prioritizes groups at risk of severe disease. These include people living with HIV/AIDS with immunosuppression and a CD4 T-lymphocyte count below 200 cells in the past six months, and laboratory professionals working at biosafety level 2.
The vaccine also covers people who had contact with fluids or secretions from suspect cases. In that exposure scenario, the dose should ideally be given within four days, extendable up to 14 days if no symptoms appear, per the State Health Secretariat.
The state’s IST/Aids and Viral Hepatitis Coordination monitors data daily and updates its epidemiological panel weekly, and Prosdocimi said state teams stay in constant contact with municipal professionals on diagnosis and case management.
What the case shows about containment
The Montes Claros timeline — symptoms on November 4, care sought on November 9, notification on November 11, laboratory confirmation on November 16 — illustrates both the value and the limits of the surveillance system. Contact tracing began only after confirmation, twelve days after symptoms began, which is why officials keep pressing the message of early testing at the first sign of characteristic lesions.
For patients who develop fever with skin eruptions or unexplained lesions, clinicians at infectious disease clinics and diagnostic laboratories can arrange mpox testing and supportive care; a basic health unit remains the recommended first point of contact in Brazil’s public system.
The state’s epidemiological panel, updated weekly, will show whether this case stays isolated or marks the start of a wider local chain of transmission.
Montes Claros, the city at the center of this case, sits in the north of Minas Gerais, about 422 km from the state capital, Belo Horizonte. Its origins trace back to 1707, when Antônio Gonçalves Figueira received a royal land grant forming the Montes Claros Farm, and a settlement grew around a chapel built on part of that land.
The municipality was established by the Law of October 13, 1831, and elevated to city status in 1857. According to the 2022 census, it has a population of 414,240, making it the fifth most populous municipality in Minas Gerais, and it has long established itself as a regional industrial hub, with industry and commerce as key economic drivers.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.